Image-based ex vivo drug screen to assess targeted therapies in recurrent thymoma
Thymus is a small gland located beneath breastbone. It is part of the lymph system and plays a key role in adaptive immune system with a function to produce and mature lymphocytes. Thymoma is a subtype of thymic epithelial tumors (TET) originating from the thymic epithelium from thymus gland. Based on the incidence rate of 0.15 cases per 100 000, thymoma is classified as a rare cancer [1]. Thymomas are best known for their association with myasthenia gravis, a neuromuscular junction disease related to skeletal muscle weakness [2].
Source: Lung Cancer - Category: Cancer & Oncology Authors: Antti Arjonen, Rami M äkelä, Ville Härmä, Nina Rintanen, Teijo Kuopio, Juha Kononen, Juha K. Rantala Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Epithelial Cancer | Lung Cancer | Myasthenia Gravis | Neurology